Mesoblast Ltd (MESO)
7.10
+0.86
(+13.78%)
USD |
NASDAQ |
Apr 29, 16:00
6.69
-0.41
(-5.77%)
After-Hours: 04:22
Mesoblast Cash from Financing (TTM): 74.50M for June 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 74.50M |
March 31, 2023 | 33.53M |
December 31, 2022 | 33.50M |
September 30, 2022 | 32.58M |
June 30, 2022 | -9.87M |
March 31, 2022 | -9.891M |
December 31, 2021 | 99.04M |
September 30, 2021 | 99.84M |
June 30, 2021 | 108.53M |
March 31, 2021 | 193.74M |
December 31, 2020 | 87.31M |
September 30, 2020 | 137.68M |
June 30, 2020 | 131.10M |
March 31, 2020 | 48.10M |
December 31, 2019 | 62.75M |
Date | Value |
---|---|
September 30, 2019 | 34.47M |
June 30, 2019 | 71.61M |
March 31, 2019 | 70.63M |
December 31, 2018 | 87.74M |
September 30, 2018 | 67.27M |
June 30, 2018 | 68.61M |
March 31, 2018 | 69.73M |
December 31, 2017 | 97.99M |
September 30, 2017 | 98.51M |
June 30, 2017 | 60.00M |
March 31, 2017 | 59.92M |
December 31, 2016 | 0.075M |
September 30, 2016 | 61.84M |
June 30, 2016 | 62.07M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-9.891M
Minimum
Mar 2022
193.74M
Maximum
Mar 2021
72.26M
Average
71.61M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Immuron Ltd | -0.0306M |
Alterity Therapeutics Ltd | 33.78M |
Kazia Therapeutics Ltd | 7.850M |
Immutep Ltd | 13.70M |
Opthea Ltd | 138.48M |